A study has found that two years after biosimilars became available in the U.S., a higher proportion of patients using brand-name biologics were paying out-of-pocket costs, which were also, on average, 12% higher than before. In addition, patients who used biosimilars often did not pay lower out-of-pocket costs than those who were given brand-name biologic medicines. The findings suggest that the arrival of biosimilars has failed to fully deliver on their promise of lower costs for patients.
Auto insurance rates have been on an upward trajectory since 2022, contributing to inflation and putting a strain on car owners. Factors contributing to this rise include the increasing cost of new vehicles, more expensive repairs due to technological advancements, and longer wait times to replace parts. Insurers have responded by raising premiums, leading to significant profits for industry giants. However, consumers can take steps to mitigate the impact by shopping around for quotes, considering different deductible options, and bundling insurance policies. Understanding the intricacies of auto insurance and taking defensive driving courses can also help reduce costs.
